Dr. Robert Miller, MD

• Oncology

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mayo Clinic-rochester

  Residency Hospital, 1998

• University Of Kentucky College Of Medicine

  Internship Hospital, 1994

• American College of Healthcare Executives, Member

• ALMC Board Compensation Committee Mayo Clinic Health System in Albert Lea Mayo Clinic Health System, Chair

• Protocols Review Committee Cancer Research Committee Mayo Clinic Cancer Center Rochester, Member

• Melanoma Disease Oriented Group Disease Discipline Oriented Groups DOGs Mayo Clinic Cancer Center, Member

• MHS Leadership Roundtable Mayo Clinic Health System, Committee Member

• Esophageal Adenocarcinoma and Barretts Esophagus Registry Steering Committee, Member

• Sino American Network for Therapeutic Radiology and Oncology, Member

• ASTRO Membership Committee American Society for Therapeutic Radiology and Oncology, Member

• Evaluation Subcommittee Emerging Technologies Steering Committee Health Policy Council, Member

• Mayo Clinic Cancer Center, Member

• Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial, 2018-11-02

• Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993), 2011-09-16

• Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung, 2015-01-14

• Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT, 2023-07-27

• Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: Efficacy of a low daily dose to clinically negative regions, 2011-10-06

• Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review, 2018-09-05

• The clinical case for proton beam therapy, 2012-10-22

• Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma, 2012-05-03

• Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-related Oral Mucositis Pain: the Alliance A221304 Randomized Clinical Trial, 2019-04-16

• COMPARISON OF PROVIDER-ASSESSED AND PATIENT-REPORTED OUTCOME MEASURES OF ACUTE SKIN TOXICITY DURING A PHASE III TRIAL OF MOMETASONE CREAM VERSUS PLACEBO DURING BREAST RADIOTHERAPY: THE NORTH CENTRAL CANCER TREATMENT GROUP (N06C4), 2010-10-01

• Radiotherapy plus Chemotherapy with or without Surgical Resection for Stage III Non-Small Cell Lung Cancer, 2009-07-24

• Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9, 2021-05-11

• Induction vs no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in esophageal adenocarcinoma: a multicenter randomized phase II trial (NCCTG N0849 [Alliance]), 2021-04-29

• Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival, 2019-06-11

• Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control study, 2012-02-16

• Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules, 2015-02-18

• Genetic testing for young-onset colorectal cancer: case report and evidence-based clinical guidelines, 2010-03-18

• American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology, 2017-12-15

• Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase 3 Double-Blind, Randomized Trial from the North Central Cancer Treatment Group N06C4, 2010-08-26